| NCT03330834 |
– |
Sun Yat-sen University; Guangzhou Yiyang Biological Technology Co., Ltd. |
Phase 1 |
| NCT03525782 |
MUC1, PD-1 |
The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Anjie Biomedical Technology Co., Ltd.; University of Technology, Sydney |
Phase 1/2 |
| NCT04153799 |
EGFR |
Sun Yat-sen University; Guangzhou Bio-gene Technology Co., Ltd. |
Phase 1 |
| NCT03198052 |
HER2/MSLN/Lewis-Y/PSCA/MUC1/PD-L1/CD80/86 |
Second Affiliated Hospital of Guangzhou Medical University; Hunan Zhaotai Yongren Medical Innovation Co. Ltd.; Guangdong Zhaotai In Vivo Biomedicine Co. Ltd.; First Affiliated Hospital, Sun Yat-sen University |
Phase 1 |
| NCT02587689 |
MUC1 |
PersonGen BioTherapeutics (Suzhou) Co., Ltd.; The First People’s Hospital of Hefei; Hefei Binhu Hospital |
Phase 1/2 |
| NCT02349724 |
CEA |
Southwest Hospital, China |
Phase 1 |
| NCT03198546 |
GPC3 |
Second Affiliated Hospital of Guangzhou Medical University; Hunan Zhaotai Yongren Medical Innovation Co. Ltd.; Guangdong Zhaotai InVivo Biomedicine Co. Ltd.; First Affiliated Hospital, Sun Yat-sen University |
Phase 1 |
| NCT04025216 |
TnMUC1 |
Tmunity Therapeutics |
Phase 1 |
| NCT03356808 |
– |
Shenzhen Geno-Immune Medical Institute |
Phase 1/2 |
| NCT02713984 |
HER2 |
Zhi Yang; Southwest Hospital, China |
Phase 1/2 |
| NCT03638206 |
– |
Shenzhen BinDeBio Ltd.; The First Affiliated Hospital of Zhengzhou University |
Phase 1/2 |
| NCT01583686 |
MSLN |
National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC) |
Phase 1/2 |
| NCT02414269 |
MSLN |
Memorial Sloan Kettering Cancer Center |
Phase 1 |
| NCT02706392 |
ROR1 |
Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI) |
Phase 1 |
| NCT03054298 |
MSLN |
University of Pennsylvania |
Phase 1 |
| NCT03740256 |
HER2 |
Baylor College of Medicine; The Methodist Hospital System; Texas Children’s Hospital |
Phase 1 |
| NCT02862028 |
PD-1, EGFR |
Shanghai International Medical Center |
Phase 1/2 |
